INTRODUCTION
The basal forebrain (BF) cholinergic system has a central role in the state-dependent control of brain function, acting to powerfully modulate cognitive processing and sensory perception (Everitt and Robbins, 1997; Goard and Dan, 2009; Hasselmo and Sarter, 2011; Herrero et al., 2008; Liu et al., 2017; Parikh et al., 2007; Pinto et al., 2013; Winkler et al., 1995) . Consistent with this, in human diseases of cognition, such as age-dependent cognitive decline and forms of dementia, the progressive degeneration of BF cholinergic nuclei correlates with the degree of cognitive impairment (Bartus et al., 1982; Grothe et al., 2013; Whitehouse et al., 1982) .
Recent work has examined the neocortical circuit elements controlled by the synaptic release of ACh from BF cholinergic axons, which ramify throughout the neocortical layers, revealing that the activation of nicotinic ACh receptors (nAChRs) excites principal neurons and specific inhibitory interneuronal circuits Chen et al., 2015; Fu et al., 2014; Hedrick and Waters, 2015; Letzkus et al., 2011; Saunders et al., 2015) . Notably, however, the pharmacological manipulation of muscarinic AChRs (mAChRs) significantly influences human cognition, and attentive processing in animals (Everitt and Robbins, 1997; Hasselmo and Sarter, 2011; Herrero et al., 2008) , by actions thought to be mediated, in part, by the direct modulation of axo-somatic ion channels and the regulation of intracellular calcium-dependent processes in principal neurons (Battefeld et al., 2014; Dasari et al., 2017; Giessel and Sabatini, 2010; Hasselmo and Sarter, 2011; Krnjevi c et al., 1971; Nicoll et al., 1990) . Surprisingly, however, little attention has been focused on the role of the cholinergic system in the control of principal neuron dendritic excitability, despite a wealth of evidence indicating that active dendritic processing is a critical determinant of behaviorally engaged neuronal computations and sensory perception (Basu et al., 2016; Bittner et al., 2015; Gambino et al., 2014; Harnett et al., 2013; Murayama and Larkum, 2009; Sheffield and Dombeck, 2015; Smith et al., 2013; Takahashi et al., 2016; Xu et al., 2012) . As the BF cholinergic system is engaged during active behavior (Eggermann et al., 2014; Hangya et al., 2015; Parikh et al., 2007) to regulate sensory responsiveness and perception (Fu et al., 2014; Goard and Dan, 2009; Herrero et al., 2008; Nuñ ez et al., 2012; Pinto et al., 2013) , we investigated whether the endogenous release of ACh modulates dendritic information processing in neocortical principal neurons.
RESULTS
To directly examine whether activation of the cholinergic system dynamically controls dendritic information processing in the principal output neurons of the neocortex, we made simultaneous whole-cell recordings from the soma and distal apical dendrites of layer 5B (L5B) pyramidal neurons in brain slices of the somatosensory neocortex prepared from mice which selectively expressed channelrhodopsin-2 (ChR2) in cholinergic neurons under the control of the cholineacetyltransferase (ChAT) promoter (Pinto et al., 2013; Saunders et al., 2015) (Figures 1, S1 , and S2; dendritic recording distance from soma = 515 ± 10 mm; n = 23). The optogenetic-evoked release of ACh from cholinergic axons, which ramified throughout the neocortical layers, was found to profoundly and selectively modulate the electrical excitability of apical dendrites ( Figures 1A-1D and S1). In each neuron tested, a brief (4 ms) full-field photoactivation light pulse centered at the dendritic recording site transformed the output of dendritic integration from a single dendritic spike that drove a transient burst of action potential (AP) output to long-duration dendritic plateau potentials, which evoked sustained trains of AP firing ( Figures 1A, 1D , S3A, and S3D; n = 66 trials, n = 13 neurons; dendritic current step: amplitude = 0.63 ± 0.04 nA, duration = 0.5 s). This transformation was apparent both immediately (50 ms) and 3.55 s after photoactivation and subsequently decayed with an (A) Optogenetic-evoked ACh release (4 ms full-field stimuli, blue symbol) powerfully facilitates apical dendritic excitability and transforms the impact of dendritic excitatory input on action potential (AP) output. Three overlain voltage responses simultaneously recorded from the dendrite (V dend , red traces) and soma (V soma , black traces) are shown, together with positive current steps injected at the dendritic recording site (I dend ). The lower traces show dendritic current-evoked voltage responses generated before and 3.55 s after photoactivation at a faster time base. (B) Reconstruction of the recorded L5B pyramidal neuron (white) overlain on simultaneously imaged EYFP-labeled cholinergic axons. The placement of recording electrodes is shown schematically. (C) Optogenetic-evoked ACh release has a minimal impact on somatic current-evoked AP output (same neuron as shown in A and B). (D) Cumulative probability distributions of the number of APs evoked by dendritic (left graph) and somatic (right graph) positive current steps delivered before and after photoactivation. (E) The selective M1 AChR antagonist telenzepine (100 nM) blocks the enhancement of dendritic excitability and the transformation of AP output evoked by optogenetic activation; responses shown were generated 3.55 s after photoactivation. (F) Cumulative probability distribution of the number of APs evoked by dendritic current steps generated 3.55 s after optogenetic activation under control and in the presence of telenzepine. (G) Simultaneous somato-dendritic recording of the synaptic response evoked by optogenetic activation alone. The resting membrane potential at somatic and dendritic recording sites are indicated, same neuron as shown in (A)-(C). (H and I) Antagonism of nicotinic AChRs (hexamethonium, HEX, 100 mM, n = 11) blocks the excitatory response evoked by optogenetic activation alone, to reveal delayed mAChR-mediated inhibition. Values represent mean ± SEM. See also Figures S1-S5. exponential time course ( Figures 1A, 1D , 2A-2D, S3A, and S3D; distribution significantly different from before photoactivation, Kolmogorov-Smirnov test, p < 0.0001 [50 ms], p < 0.0001 [3.55 s]; decay time constant = 23.1 s, n = 13 neurons). This cholinergic modulation of dendritic excitability was unaccompanied by changes in dendritic membrane potential, input resistance, or the area of subthreshold dendritic voltage responses, suggesting the neuromodulation of specific classes of ion channels ( Figures  1A, 1D , and 2A-2D; D membrane potential = 0.23 ± 0.08 mV, n = 13 neurons; D apparent input resistance = 0.65 ± 0.21 MU). In contrast to the powerful control of dendritic excitability, simultaneous somatic recording demonstrated that the brief (4 ms) optogenetic-evoked release of ACh had a minimal direct influence on axo-somatic excitability, failing to significantly alter the number of APs evoked by somatic positive current steps, when full-field photoactivation was centered at somatic or dendritic sites ( Figures 1C, 1D , S3B, and S3E; distributions not significantly different from before photoactivation, Kolmogorov-Smir-nov test, p = 0.3359 [50 ms], p = 0.2402 [3.55 s], n = 68 trials, n = 13 neurons; somatic current step: amplitude = 0.30 ± 0.04 nA, duration = 0.5 s). Together, these data reveal that the cholinergic system acts to specifically modulate dendritic excitability in the principal output neurons of the neocortex.
Muscarinic AChRs Mediate the Cholinergic Control of Dendritic Excitability
Pharmacological analysis revealed that the optogenetic-evoked cholinergic enhancement of apical dendritic excitability was abolished by the selective antagonism of M1 AChRs ( Figures  1E, 1F , and S3C; number of APs after [3.55 s] photoactivation: control = 11.7 ± 1.1, telenzepine [100 nM] = 2.1 ± 0.1; t test, p = 0.0005, n = 37 trials, n = 7 neurons). In contrast, the broadspectrum nAChR antagonist hexamethonium did not alter the cholinergic transformation of dendritic excitability (area of dendritic response; control: before = 14.2 ± 0.8 mV.s, after [3.55 s] = 26.2 ± 1.9 mV.s; hexamethonium: before = 15.4 ± 0.8 mV.s, after [3.55 s] = 25.9 ± 1.7 mV.s; t test, not significantly different, n = 5). The antagonism of nAChRs, however, blocked the small-amplitude, short-duration excitatory postsynaptic potentials (EPSPs) evoked by optogenetic activation when delivered in isolation (Hedrick and Waters, 2015) to reveal a slower muscarinic AChR-mediated inhibitory component ( Figures 1G-1I ; EPSP control: amplitude = 1.65 ± 0.31 mV; area = 0.138 ± 0.08 mV.s, hexamethonium: amplitude = 0.18 ± 0.04 mV; area = À0.31 ± 0.11 mV.s, amplitude: t test, p = 0.0007; area: t test, p = 0.0087, n = 11 neurons; IPSP control: amplitude = À0.31 ± 0.07 mV; telenzepine = À0.03 ± 0.02 mV; t test, p = 0.017, n = 11). Consistent with previous reports, optogenetic activation also evoked shortduration nAChR-mediated EPSPs in supragranular neocortical interneurons Bennett et al., 2012; Saunders et al., 2015) ( Figures S4 and S5 ). The amplitude of nAChR-mediated EPSPs was interneuron-class-dependent and exhibited, in common with nAChR-mediated EPSPs recorded from L5B pyramidal neurons, prominent paired-pulse depression ( Figures S4 and S5 ; pairedpulse depression [3 s]: interneurons = 0.57 ± 0.02, n = 22; L5B = 0.59 ± 0.03, n = 20; Mann-Whitney, not significantly different, p = 0.990). In contrast to the long-lasting control of L5B pyramidal neuron apical dendritic excitability, the optogenetic-evoked release of ACh did not lead to a sustained enhancement of the excitability of interneurons ( Figures S5F and S5G ; number of APs evoked by current pulses: before = 6.7 ± 0.3; after [3.55 s] photoactivation = 7.0 ± 0.3; Kolmogorov-Smirnov test, not significantly different, p = 0.5996, n = 80 trials, n = 16 neurons).
To explore the profile of cholinergic activation which triggered the generation of short-duration nAChR-mediated EPSPs in interneurons and L5B pyramidal neurons when evoked in isolation, and the selective longer-lasting M1 AChR-mediated enhancement of suprathreshold apical dendritic excitability in L5B pyramidal neurons, we investigated the pattern of AP firing evoked by optogenetic activation of BF cholinergic neurons ( Figures 2E-2G , S4, and S6). Direct recording from identified nucleus basalis (NB) magnocellular cholinergic neurons, which widely innervate the neocortex (Kalmbach et al., 2012) , revealed that brief (4 ms) full-field optogenetic stimuli evoked a single AP in 454 of 468 trials in cell-attached and whole-cell recordings (Figures 2E-2G; latency to AP peak = 8.42 ± 0.06 ms, n = 14 visually targeted in brain slices prepared from ChAT-Cre-ChR2-EYFP mice), a finding consistent with the time-locked and transient AP firing of this population of neurons during reinforcement behavior (Hangya et al., 2015) . Furthermore, because of the long-lasting after-hyperpolarization potentials which followed APs (Hedrick and Waters, 2010) , a single AP was evoked in NB magnocellular cholinergic neurons by longer-duration light stimuli (4-20 ms; n = 13), and repetitive low-frequency AP firing was only manifest in response to prolonged periods of photoactivation ( Figure S6 ; AP firing rate [1 s photoactivation] = 3.7 ± 1.1 Hz, n = 6; rheobase step current-evoked AP threshold = À33.1 ± 1.0 mV; fast AP after-hyperpolarization potential = À26.8 ± 1.9 mV; slow AP after-hyperpolarization potential = À36.9 ± 1.2 mV, n = 14). Consistent with this, the time course of nAChR-mediated EPSPs recorded from supragranular neocortical interneurons did not change when the duration of the optogenetic activation pulse was increased from 4 to 20 ms (Figures S4H and S4I; EPSP half-width [4 ms] = 125.0 ± 7.0 ms; EPSP half-width [20 ms] = 135 ± 9.2 ms; t test, not significantly different, p = 0.193, n = 6). Furthermore, analysis of nAChRmediated EPSPs in interneurons revealed that their onset latencies exhibited trial-to-trial temporal jitter consistent with the jitter in the timing of APs evoked in NB magnocellular cholinergic neurons in response to identical light stimuli (Figures S4A and S4D) . Similarly, brief optogenetic stimuli evoked a transient, highly time-locked, burst of AP firing in a sparsely distributed population of identified cholinergic neocortical interneurons (von Engelhardt et al., 2007) ( Figure S7 ; light stimuli [4 ms]: APs per trial = 1.86 ± 0.03; inter-spike frequency = 280.3 ± 1.7 Hz; latency to AP peak = 9.61 ± 0.07 ms; n = 576 trials, n = 12 neurons). Together, these data suggest that the brief optogenetic activation of cholinergic axons drives transient AP firing, leading to the phasic release of ACh, which in L5B pyramidal neurons evokes a long-lasting enhancement of apical dendritic excitability through the action of metabotropic AChRs.
Consistent with this pharmacological profile, simultaneous dendro-somatic recordings from rat L5B pyramidal neurons revealed that the bath application of the mAChR agonist muscarine (2.5 mM) transformed the pattern of dendritic-current-evoked electrogenesis, leading to the generation of longduration dendritic plateau potentials, which drove repetitive AP firing (Figures 3A-3C; dendritic recording distance from soma = 715 ± 17 mm; dendritic excitation, AP firing rate: control = 2.9 ± 0.3 Hz, muscarine [2.5 mM] = 22.1 ± 1.8 Hz, t test, p < 0.0001, n = 16; dendritic excitation, current step: amplitude = 1.6 nA, duration = 0.6 s). This positive modulation of dendritic signaling was unaccompanied by changes in apparent input resistance or the current threshold for dendritic spike initiation (D apparent input resistance = 0.78 ± 0.58 MU; dendritic spike rheobase: control = 1.19 ± 0.03 nA, muscarine [2.5 mM] = 1.21 ± 0.04 nA, t test, p = 0.497; D membrane potential = À1.15 ± 0.25 mV, t test, p = 0.0005, n = 16). In common with optogenetic experiments, the pharmacological activation of mAChRs did not positively modulate axo-somatic excitability in rat L5B pyramidal neurons (Figures 3A and 3D; AP rheobase: control = 0.66 ± 0.03 nA, muscarine = 0.6 ± 0.03 nA, t test, not significantly different, p = 0.056; AP firing rate: control = 45.3 ± 2.1 Hz, muscarine [2.5 mM] = 39.5 ± 2.0 Hz, t test, p = 0.0018; amplitude = 1.6 nA, duration = 0.6 s) or influence the somatic membrane potential when measured with non-invasive recording techniques ( Figure S8 ; somatic membrane potential: control = À70.8 ± 1.7 mV muscarine [2.5 mM] = À71.2 ± 1.7 mV; t test, not significantly different, p = 0.386, n = 14).
To confirm that the local apical dendritic activation of mAChRs was sufficient to account for the cholinergic control of excitability in rat L5B pyramidal neurons, we selectively activated distal apical dendritic mAChRs by the pressure application of muscarine from a pipette placed close to the dendritic recording site (Figures 3E-3H; puffer pipette contained 10 mM muscarine; dendritic recording distance from soma = 686 ± 14 mm; n = 11). The local dendritic activation of mAChRs dramatically and reversibly transformed apical dendritic excitability, leading to the generation of dendritic plateau potentials, which drove repetitive AP firing but neither altered the dendro-somatic attenuation of subthreshold voltage responses nor increased axo-somatic excitability ( Figures 3E-3H ; somatic current-evoked AP firing rate: control = 13.4 ± 1.4 Hz, muscarine = 12.6 ± 1.3 Hz; current step: amplitude = 0.71 ± 0.06 nA, duration = 0.6 s). Together, these findings reveal that the activation of mAChRs powerfully and selectively modulates the dendritic excitability of mouse and rat L5B pyramidal neurons.
Cholinergic Control of Dendritic Computations
Dendritic computations in the output neurons of the cortex are fundamental components of behaviorally engaged neocortical circuit activity, functioning to signal object location in the somatosensory cortex and drive sensory perceptual detection (Harnett et al., 2013; Takahashi et al., 2016; Xu et al., 2012) . Mechanistically, these computations are generated by the associative inte-gration of feedforward intra-columnar circuit activity and feedback contextual signals, the latter of which are conveyed in long-range pathways that target layer 1 of the neocortex, through the supralinear interaction between axo-somatic and apical dendritic integration compartments (Harnett et al., 2013; Larkum et al., 1999; Takahashi et al., 2016; Williams, 2005; Xu et al., 2012) . To explore whether the synaptic release of ACh controls such associative computations, we injected pseudo-random barrages of simulated excitatory postsynaptic currents (EPSCs) at somatic and distal apical dendritic sites of L5B pyramidal neurons under control conditions and following the optogenetic activation of cholinergic axons in ChAT-Cre-ChR2-EYFP mice (Figures 4A-4C; dendritic recording distance from soma = 515 ± 32 mm; n = 5). Under control conditions, trains of somatic (B) Pooled apical dendritic current-discharge relationship shows the mAChR-mediated enhancement of AP output evoked by dendritic excitatory input (muscarine, Musc., 2.5 mM, blue symbols). This action was antagonized by ipratropium bromide (Ipra., 10 mM, gray symbols). (C) Peri-stimulus time histogram of the mAChR-mediated (blue bars) transformation of the pattern of AP output evoked by dendritic current steps. (D) Pooled somatic current-discharge relationships demonstrate that mAChR activation does not enhance AP output evoked by somatic excitatory input. (E) Local apical dendritic application of muscarine enhances dendritic excitability. Overlain contrast and fluorescence images show the position of the dendritic recording electrodes, the Alexa 594 dye-filled neuron, and the placement of a puffer pipette. Simultaneous somatic (black traces) and apical dendritic (red traces) recordings illustrate the reversible enhancement of dendritic excitability produced by the local dendritic application of muscarine (10 mM).
(F-H) Reversible enhancement of supra-threshold apical dendritic voltage responses (F), and dendritic-current-evoked AP firing (G) by the local dendritic application of muscarine. Note that local dendritic application of muscarine did not alter the dendro-somatic attenuation of subthreshold voltage responses (H). (C) The optogenetic-evoked enhancement of associative integration is antagonized by the M1 AChR antagonist telenzepine (100 nM, black shaded symbols; n = 5 neurons). The inset raster plot shows AP firing evoked by paired input in five consecutive trials following optogenetic activation under control (blue) and in the presence of telenzepine (100 nM, black). (D) Apical dendritic tuft recording (V tuft , 840 mm from soma) demonstrates that mAChR activation (muscarine 2.5 mM) enhances apical dendritic tuft electrogenesis generated by the pairing of an apical dendritic trunk spike (green traces, paired) with subthreshold apical dendritic tuft depolarization in a rat L5B pyramidal neuron.
(E) Multi-site somatic (V soma ), apical dendritic (V dend , 650 mm from soma), and tuft (V tuft , 760 mm from soma) recordings demonstrate that mAChR activation (Musc., 2.5 mM) increases AP output evoked by the pairing of apical tuft depolarization with dendritic trunk spike generation in a rat L5B pyramidal neuron. Neuronal morphology is shown in the inset. (F) Relationship between the half-width of apical dendritic tuft electrogenesis and the time overlap between positive current steps delivered at apical dendritic trunk and tuft sites under the indicated conditions. (G) AP output evoked by a family of increasing duration dendritic tuft current steps under control and following mAChR activation. All values represent mean ± SEM. See also Figure S9 . and dendritic EPSCs were associatively integrated, resulting in the generation of brief envelopes of dendritic electrogenesis that drove bursts of AP output ( Figure 4A ). This pattern of associative integration was powerfully facilitated by the optogenetic-evoked release of ACh (4 ms full-field photoactivation pulse), leading to the generation of long-lasting dendritic plateau potentials that significantly enhanced AP output in a M1 AChRdependent manner (Figures 4A-4C ; control = 24.4 ± 0.9 Hz, photoactivation = 40.0 ± 0.7 Hz; t test, p < 0.0001; photoactivation + telenzepine [100 nM] = 25.3 ± 0.8 Hz; n = 28 trials, n = 5). The transformation of this dendritic computation was replicated by the pharmacological activation of mAChRs in rat L5B pyramidal neurons ( Figure S9 , n = 13), allowing us to directly explore whether cholinergic modulation controls the excitability of the apical dendritic tuft. In behaving animals, long-lasting calcium electrogenesis has been found to be generated in the apical dendritic tuft of L5B pyramidal neurons only during active sensation (Harnett et al., 2013; Xu et al., 2012) . To test whether cholinergic activation is necessary for the production of such long-lasting apical dendritic tuft signaling, we made dual current-clamp recordings from fine-caliber apical dendritic tuft branches, and distal apical dendritic trunk sites of rat L5B pyramidal neurons ( Figure 4D ). At these sites, the activation of mAChRs significantly and reversibly enhanced the duration of voltage responses evoked by the pairing of dendritic trunk spikes with subthreshold apical dendritic tuft excitatory input ( Figures 4D and 4F ; tuft recording distance from the base of the apical dendritic tuft = 95 ± 8 mm; tuft half-width: control unpaired = 23.6 ± 4.2 ms; paired [200 ms overlap] = 39.2 ± 5.0 ms; t test, p = 0.0003; muscarine [2.5 mM]: unpaired = 25.2 ± 2.2 ms; paired [200 ms overlap] = 275.7 ± 50.3 ms; t test, p = 0.0011, n = 9). Furthermore, triple somatic, apical dendritic trunk, and dendritic tuft recordings revealed that mAChR-mediated enhancement of apical dendritic tuft excitability significantly impacted on AP output by transforming the flat relationship between the duration of apical dendritic tuft subthreshold excitatory input and AP output under control to a steep increase in neuronal output as the duration of apical dendritic tuft excitatory input was increased (Figures 4E and 4G) . Together, these data reveal that the cholinergic system powerfully facilitates behaviorally relevant dendritic computations by controlling the gain of apical dendritic integration in rat and mouse L5B pyramidal neurons.
Effector Mechanisms
To dissect the effector mechanisms underlying the cholinergic transformation of dendritic excitability, we first examined if this action was mediated by an intracellular calcium-dependent mechanism, a common mAChR-mediated signaling cascade (Dasari et al., 2017) . Surprisingly, when intracellular calcium levels were regulated by the inclusion of the fast calcium chelator BAPTA (10 mM) in somatic and dendritic recording electrodes, the activation of mAChRs in rat L5B pyramidal neurons powerfully and selectively augmented dendritic electrogenesis, suggesting that enhancement of dendritic excitability is not mediated by mAChR-triggered rises in intracellular calcium (Figures 5A and 5B ; dendritic-current-evoked AP firing rate: control = 3.3 ± 0 Hz, muscarine = 50.3 ± 8.6 Hz; t test, p = 0.0056, n = 5; somatic current-evoked AP firing rate: control = 59.6 ± 4.0 Hz, muscarine = 62.1 ± 5.2 Hz; t test, not significantly different, p = 0.215; current step: amplitude = 1.6 nA, duration = 0.6 s). We therefore sought to determine the identity of the ionic conductance(s) modulated by mAChR activation. Notably, when the muscarine-sensitive potassium conductance I M or tetrodotoxin (TTX)-sensitive sodium channels were pharmacologically blocked with XE991 (5 mM) (Battefeld et al., 2014) and TTX (1 mM), respectively, mAChR activation consistently augmented dendritic excitability ( Figures 5C and 5D ; dendritic voltage area: TTX + XE991 = 25.8 ± 2.6 mV.s, muscarine = 39.5 ± 2.8 mV.s, t test, p = 0.0103, n = 6; current step: amplitude = 1.5 nA, duration = 0.6 s). Similarly, when hyperpolarization-activated cyclic nucleotide-gated non-selective cation (HCN) channels, which have been demonstrated to control distal apical dendritic excitability (Harnett et al., 2015) , were blocked (ZD7288, 10 mM), mAChR-activation led to the generation of dendritic plateau potentials ( Figures 5E and 5F ; dendritic voltage area TTX + ZD7288 = 32.7 ± 1.7 mV.s, muscarine = 53.5 ± 1.9 mV.s, t test, p < 0.0001, n = 8; current step: amplitude = 1.6 nA, duration = 0.6 s). In contrast, when sodium, HCN, and calcium channels were antagonized, a milieu that completely blocked apical dendritic regenerative activity (Figures S10A-S10D; n = 9), mAChR activation failed to alter the pattern of outward rectification of voltage responses evoked by families of dendritic positive current steps ( Figures 5G and 5H ; calcium channels blocked with cadmium [100 mM] + 1 mM [Ca 2+ ] o , 6 mM [Mg 2+ ] o ; dendritic voltage area = 48.6 ± 1.6 mV.s, muscarine = 50.7 ± 1.7 mV.s; t test, not significantly different, p = 0.439, n = 8; dendritic current step: amplitude = 2.0 nA, duration = 0.6 s). As the rectification of this relationship was linearized by the pharmacological blockade of potassium channels, which are expressed at high densities in the apical dendritic arbor of L5B pyramidal neurons (Harnett et al., 2013) , these data suggest that mAChR activation modulates dendritic calcium, but not potassium conductances, in L5B pyramidal neurons ( Figure 5H ; potassium channels blocked with tetraethylammonium [TEA, 20 mM], 4-aminopyridine [4-AP, 5 mM] and quinidine [25 mM]; dendritic voltage integral = 62.1 ± 3.7 mV.s, t test, p = 0.0008, n = 8). Consistent with this interpretation, the activation of mAChRs failed to modulate ensemble voltage-gated potassium channel function recorded under conditions of ideal voltage clamp in nucleated patches ( Figure S11 ) or dendritic potassium conductance in dendritic whole-cell voltage-clamp recordings ( Figure S11 ) and cell-attached patches ( Figure S12 ).
Nucleated patch recordings from rat L5B pyramidal neurons, however, demonstrated that mAChR activation significantly and reversibly increased the peak amplitude and charge of pharmacologically isolated cadmium-sensitive calcium currents ( Figures 6A-6C ; control = À101.5 ± 5.4 pA, muscarine [5 mM] = À152.8 ± 8.1 pA, ANOVA, p < 0.0001; wash = À108.8 ± 5.3 pA; p < 0.0001, n = 16; control = À96.5 ± 8.4 pA, cadmium [50 mM] = À4.2 ± 4.3 pA, t test, p < 0.0001, n = 13). Analysis revealed that this positive modulation was apparent throughout the high-threshold activation range of the calcium conductance ( Figure 6D) and was antagonized by pre-incubation with the mAChR antagonist ipratropium bromide (10 mM) ( Figure 6B ; ipratropium bromide = À95.0 ± 10.1 pA, + muscarine [5 mM] = À101.3 ± 13.4 pA, t test, not significantly different, p = 0.334, n = 8). Similarly, at distal dendritic sites, the activation of mAChRs significantly increased the amplitude and charge of dendritic high-threshold calcium currents recorded in whole-cell voltage-clamp mode, an effect antagonized by preincubation with ipratropium bromide (Figures 6E-6H ; peak amplitude = À98.8 ± 17.8 pA, muscarine [5 mM] = À140.6 ± 20.3 pA, t test, p = 0.012; distance from soma = 776 ± 23 mm; peak amplitude: ipratropium bromide [10 mM] = À120.4 ± 9.3 pA, + muscarine [5 mM] = À109.0 ± 9.9 pA, t test, not significantly different, p = 0.152, n = 5). In order to minimize the regenerative activation of high-threshold calcium currents, dendritic whole-cell recordings were made using an extracellular solution designed to pharmacologically isolate and attenuate the high-threshold calcium conductance (Harnett et al., 2013; Williams and Mitchell, 2008) . Under these recording conditions, the voltage dependence of the dendritic whole-cellrecorded high-threshold calcium current mirrored the voltage dependence of calcium currents recorded under ideal voltageclamp conditions from nucleated patches ( Figure 6H ). We next investigated whether mAChR activation modulated high-threshold calcium conductance on a fast timescale, as optogenetic experiments demonstrated that apical dendritic calcium electrogenesis was powerfully and rapidly modulated by the synaptic release of ACh ( Figure 1A) . This modulation could not be studied quantitatively using dendritic whole-cell voltageclamp techniques because of the regenerative activation of pharmacologically isolated calcium currents recorded under standard extracellular divalent cation concentrations (data not shown). We therefore investigated the mAChR-mediated modulation of high-threshold calcium currents on a fast timescale by transiently applying muscarine to the environment of nucleated patches ( Figure 7A , pressure application duration = 200 ms, application started 250 ms before an activation test step to 0 mV; n = 14). The transient activation of mAChRs dose-dependently enhanced the charge of high-threshold calcium conductance (control = 8.15 ± 1.04 pC; high muscarine [500 mM in application pipette] = 10.40 ± 1.38 pC; ANOVA, p = 0.0004, n = 9; control = 10.13 ± 1.18 pC; low muscarine [100 mM in application pipette] = 10.93 ± 1.40 pC; ANOVA, p = 0.0029, n = 5), a positive modulation which recovered over a period of 12 s (Figures 7B-7D ; recovery [high muscarine] = 8.17 ± 1.01 pC; ANOVA, p = 0.0005; recovery [low muscarine] = 10.03 ± 1.22 pC; ANOVA, p = 0.0014). This action was specific, as the brief pressure application of artificial cerebrospinal fluid (ACSF) did not alter the charge of the high-threshold calcium conductance ( Figures 7B  and 7D ; control = 7.95 ± 2.11 pC; ACSF = 7.96 ± 2.07 pC; not significantly different, t test, p = 0.996, n = 5). Taken together, these data indicate that the activation of mAChRs rapidly positively modulates high-threshold calcium conductance in L5B pyramidal neurons.
To determine the class of calcium channel responsible, we applied the specific calcium channel antagonist SNX-482 (Newcomb et al., 1998) , revealing that a significant component of the high-threshold calcium conductance recorded from nucleated patches was mediated by R-type calcium channels (Almog and Korngreen, 2009) (Figures 8A and 8B ; SNX-482 [100 nM, puff]: control = 10.1 ± 1.2 pC; SNX = 5.1 ± 0.4 pC; t test, p = 0.0028, n = 7; ACSF puff: control = 9.5 ± 3.4 pC; ACSF = 8.6 ± 3.5 pC; n = 3; t test, not significantly different). Consistent with this, dendritic whole-cell voltage-clamp recordings revealed that the local dendritic application of SNX-482 (200 nM in application pipette) attenuated the charge of the pharmacologically isolated high-threshold calcium conductance (Figures S10E and S10F; control = 12.99 ± 1.08 pC, dendritic SNX = 8.74 ± 1.02 pC; t test, p = 0.0002, recording distance from the base of the apical dendritic tuft = 38.7 ± 11.8 mm, n = 7). The highthreshold calcium conductance, recorded from nucleated patches, was comparably attenuated by NiCl (50 mM), a concentration specific for R-and T-type calcium channels (Magee and Johnston, 1995; Takahashi and Magee, 2009) (Figures 8A and  8B ; control = 7.4 ± 0.5 pC; NiCl [50 mM] = 4.5 ± 0.4 pC; t test, p < 0.0001, n = 19). Notably, when muscarine (5 mM) was applied to nucleated patches in the presence of NiCl (50 mM), the mAChR-mediated enhancement of the high-threshold calcium conductance was abolished, consistent with mediation by R-type calcium channels ( Figures 8C-8E ; NiCl [50 mM] = 4.3 ± 0.5 pC; + muscarine [5 mM] = 3.9 ± 0.5 pC; t test, not significantly different, n = 14). (B) Time course of the mAChR-mediated enhancement of the normalized charge of calcium currents recorded in nucleated patches (blue symbols). The positive modulation of calcium channel activity was antagonized by pre-incubation with ipratropium bromide (Ipra., 10 mM, gray symbols). The calcium current was fully blocked by cadmium (50 mM, open symbols). (C) Summary of the reversible enhancement (multiple comparison ANOVA) of calcium currents recorded in nucleated patches by muscarine. (D) Calcium currents generated in response to voltage ramps (from À100 mV to 20 mV, 2.8 V/s) reveal that mAChR activation enhances calcium currents across a wide voltage range; shaded bands indicate ± SEM. (E) Muscarinic AChR-mediated enhancement of whole-cell calcium current recorded from a distal apical dendritic site of a rat L5B pyramidal neuron (871 mm from soma). (F) Time course of the mAChR-mediated enhancement of the normalized charge of dendritic calcium currents (blue symbols). This positive enhancement of dendritic calcium currents was antagonized by ipratropium bromide (Ipra., 10 mM, gray symbols). Dendritic calcium currents were fully blocked by cadmium (100 mM, open symbols). (G) Summary of the enhancement of dendritic calcium currents by mAChR activation (t test). (H) Voltage-dependent activation of dendritic calcium currents recorded in dendritic whole-cell voltage-clamp mode. The gray symbol, and inset trace, show the current step used for analysis of mAChR-mediated modulation (E-G), and the continuous line represents an amplitude-scaled version of the voltage dependence of calcium currents recorded from nucleated patches. Values represent mean ± SEM. See also Figures S11 and S12.
To examine whether dendritic R-type calcium channels underlie the mAChR-dependent modulation of apical dendritic excitability, we made dual current-clamp recordings from distal apical dendritic sites of rat L5B pyramidal neurons ( Figures 8F-8J ). Consistent with previous reports, the application of NiCl (50 mM) significantly and reversibly decreased the amplitude of apical dendritic trunk spikes (Letzkus et al., 2006; Pé rez-Garci et al., 2013) (Figures 8F and 8G ; peak amplitude: control = 47.0 ± 2.4 mV, nickel [50 mM] = 33.6 ± 2.5 mV n = 10; t test, p < 0.0001; distance from soma = 742 ± 20 mm). Notably, in the presence of NiCl (50 mM), the bath application of muscarine (2.5 mM) failed to alter the amplitude or area of voltage responses evoked by families of dendritic positive current steps ( Figures 8H and 8I ; n = 10). In the same experiments, however, when apical dendritic spike generation was restored by washing both NiCl and muscarine from the bath, the subsequent activation of mAChRs led to the generation of powerful dendritic plateau potentials ( Figures 8H and 8J ; voltage responses significantly different when generated in response to dendritic current steps >1 nA, ANOVA, p = 0.0353 to < 0.0001, n = 5). Together, these data reveal that the cholinergic transformation of dendritic signaling in L5B pyramidal neurons is mediated by the mAChR-driven positive modulation of R-type calcium channels.
DISCUSSION
Dendritic computations underlie the associative integration of feedforward intra-columnar and feedback contextual information in the neocortex (Larkum, 2013; Larkum et al., 1999; Williams and Stuart, 2002) . In L5B pyramidal neurons, these dendritic computations are selectively engaged during active behaviors, operating to implement sensory-motor computations and to causatively control sensory perceptual discrimination (Harnett et al., 2013; Takahashi et al., 2016; Xu et al., 2012) . Here, direct recordings from the apical dendrites of mouse and rat L5B pyramidal neurons reveal that the cholinergic modulatory system powerfully controls dendritic computations by positively modulating dendritic excitability in the output neurons of the neocortex.
We demonstrate that the optogenetic-evoked release of endogenous ACh and the pharmacological activation of mAChRs profoundly increase the impact of dendritic integration on AP output. Mechanistically, this cholinergic modulation of dendritic excitability was mediated by a M1 AChR-dependent facilitation of the R-type calcium conductance, leading to the generation of long-lasting dendritic plateau potentials. This finding is supported by the mAChR-dependent facilitation of R-type calcium channels in expression systems (Kamatchi et al., 2004; Melliti et al., 2000) and hippocampal principal neurons (Park and Spruston, 2012; Tai et al., 2006) and is consistent with the predominate distribution of the Ca V 2.3 subunit of R-type calcium channels in the superficial layers of the neocortex, in the dendrites and dendritic spines of neocortical and CA1 pyramidal neurons (Parajuli et al., 2012) . Our work is, however, the first to directly demonstrate that the endogenous release of ACh positively modulates dendritic electrogenesis in principal neurons. We find that R-type calcium channels expressed across the somato-apical dendritic axis of L5B pyramidal neurons are positively modulated by the activation of mAChRs, but this modulation only translates into enhanced excitability at apical dendritic sites. One explanation for this may be that the activation of somatic R-type calcium channels does not significantly drive AP output but operates to control the repetitive generation of APs through calcium-activated effector mechanisms (Schwindt et al., 1988) . Consistent with this idea, our and previous (Almog and Korngreen, 2009) direct recordings demonstrate that the ensemble activation of somatic high-threshold R-type calcium channels contribute only a small inward current at AP initiation threshold. In contrast, dendritic electrogenesis in principal neurons is powerfully attenuated by the calcium channel antagonist NiCl at concentrations specific for R-and T-type calcium channels (Letzkus et al., 2006; Magee and Johnston, 1995; Takahashi and Magee, 2009 ), suggesting that the R-type calcium conductance signifi- (E) Summary data illustrate that the block of R-type calcium channels prevents the cholinergic modulation of calcium currents (multiple comparison ANOVA, n.s.d = not significantly different, n = 14). (F) The bath application of nickel (50 mM) reduces the amplitude of dendritic spikes. (G) Pooled data show that the antagonism of R-type calcium channels reversibly reduces the amplitude of dendritic spikes (t test, n = 10). (H) Blockade of R-type calcium channels reversibly prevents the mAChR-mediated enhancement of dendritic excitability (muscarine, 2.5 mM). The inset shows the placement of dendritic recording electrodes at the base of the apical dendritic tuft. (I and J) Summary data illustrating the blockade of the positive modulation of dendritic excitability by the antagonism of R-type calcium channels (NiCl, 50 mM, I), which was fully reversed in the five neurons tested (J). The shaded area in (J) delineates significant cholinergic enhancement (multiple comparison ANOVA, p = 0.0353 to < 0.0001). Values in (D), (E), (G), (I), and (J) represent mean ± SEM. See also Figure S10 . cantly contributes to dendritic spike generation, which exhibits a relatively depolarized initiation threshold (Harnett et al., 2013 (Harnett et al., , 2015 . It should be noted, however, that the R-type calcium channel antagonist SNX 482 fails to block dendritic spike initiation in L5B pyramidal neurons (Pé rez- Garci et al., 2013) . This disparity may arise because of the potent antagonism of the I A potassium conductance by SNX 482 (Kimm and Bean, 2014) , a potassium conductance that decisively controls dendritic excitability (Harnett et al., 2013; Hoffman et al., 1997) . The antagonism of R-type calcium and I A potassium channels by SNX 482 may therefore allow the mediation of dendritic calcium electrogenesis by other classes of high-threshold calcium conductance (Almog and Korngreen, 2014; Pé rez-Garci et al., 2013) . Our findings reveal that the cholinergic system acts to enhance dendritic R-type calcium conductance in L5B pyramidal neurons, leading to the generation of calcium electrogenesis, which may be further enhanced and maintained by the recruitment of other classes of high-threshold calcium channels (Almog and Korngreen, 2014; Pé rez-Garci et al., 2013) to outweigh the controlling actions of apical dendritic voltage-gated potassium channels (Harnett et al., 2013) and calcium-activated potassium conductances (Almog and Korngreen, 2014) . Consistent with this interpretation, the mAChR-mediated transformation of dendritic signaling in L5B pyramidal neurons was insensitive to the chelation of intracellular calcium by BAPTA, suggesting that alternative mechanisms involving the cholinergic control of calcium-activated potassium conductances (Dasari et al., 2017; Giessel and Sabatini, 2010) , even at the nano-domain scale (Eggermann et al., 2011) , are not supported. Furthermore, direct recordings and pharmacological analysis revealed that somatic and dendritic voltage-gated potassium conductances are not modulated by mAChR activation in L5B pyramidal neurons.
Previous somatic recordings have shown that the pharmacological activation of mAChRs influences the AP firing of L5 pyramidal neurons, recorded from association and primary sensory cortices, acting to both transiently reduce axo-somatic excitability through calcium-dependent mechanisms and, on slower time-scales, enhance persistent AP output (Araneda and Andrade, 1991; Baker et al., 2018; Dasari et al., 2017; Dembrow et al., 2010; Egorov et al., 2002; McCormick and Prince, 1986; Rahman and Berger, 2011) . Notably, the optogeneticevoked release of ACh has recently been reported to weakly elevate the rate of tonic AP firing in subcortical-, but not callosal-projecting, L5 pyramidal neurons of the prefrontal cortex through a complex mechanism involving the neuromodulation of K V 7 and the conductances underlying long-lasting afterdepolarizing potentials (Baker et al., 2018) . Our findings reveal that the enhancement of dendritic excitability of L5B of the somatosensory cortex was not dependent upon the modulation of axonally located K V 7 channels (Battefeld et al., 2014) and suggest that in response to the patterns of excitatory input used here, the mAChR-mediated modulation of R-type calcium channels does not act to enhance AP firing evoked by somatic excitatory input, possibly because of the enhancement of down-stream calcium-dependent mechanisms (Schwindt et al., 1988) . It remains to be tested, however, whether a projection-target-dependent (Baker et al., 2018; Dembrow et al., 2010) cholinergic modulation of axo-somatic excitability of classes of L5B in the somatosensory cortex is manifest during tonic AP firing states.
Functionally, our findings suggest that the cholinergic system has a central role in the behavioral state-dependent control of a dendritic integration (Murayama and Larkum, 2009; Takahashi et al., 2016) . Interestingly, recent work has revealed that BF cholinergic neurons uniquely encode behavioral salience, exhibiting highly time-locked and transient population activation during behavioral reward and punishment (Hangya et al., 2015) . We suggest that this cholinergic saliency signal dynamically sets the dendritic excitability of L5B pyramidal neurons to a permissive state in order to facilitate the context-dependent perception of the sensory world (Larkum, 2013; Takahashi et al., 2016; Xu et al., 2012) . This mechanism is likely to operate in addition to the well-established nAChR-mediated control of neocortical interneuronal circuit activity, which acts in part to disinhibit neocortical pyramidal neurons Chen et al., 2015; Fu et al., 2014; Letzkus et al., 2011 Letzkus et al., , 2015 Pi et al., 2013) . Moreover, cholinergic activation has been found to inhibit identified neurogliaform cells in the supragranular layers of the neocortex (Brombas et al., 2014; Letzkus et al., 2015) , acting to silence the interneurons that give rise to GABA B receptor-mediated inhibition (Tamá s et al., 2003) , which profoundly dampens dendritic electrogenesis in L5B pyramidal neurons (Palmer et al., 2012; Pé rez-Garci et al., 2006) . Thus, the activation of AChRs both promotes apical dendritic excitability and inhibits the interneurons that give rise to dendritic inhibition to dynamically gate nonlinear associative integration in the output neurons of the neocortex, a mechanism which may define neocortical circuit function during active brain states.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: otherwise stated. Welch's correction was used for samples with unequal variance. The Mann-Whitney test was used as a non-parametric test. Details of statistical tests can be found in the Results section. Statistical analysis was carried out using Prism 7 (Graphpad). Data were excluded if there were major truncation of dendritic processes obvious at the z axis border of the slice. Somatic or dendritic electrophysiological recordings were rejected if the series resistance changed by >15% during the experiment or exceeded 20 or 50 MU, respectively, if observed recordings were highly unstable, or if cells had a depolarized membrane potential relative to the norm.
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